You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

Investigational Drug Information for Ortataxel

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Ortataxel?

Ortataxel is an investigational drug.

There have been 4 clinical trials for Ortataxel. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2013.

The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, and Carcinoma, Renal Cell. The leading clinical trial sponsors are Theradex, Mario Negri Institute for Pharmacological Research, and National Cancer Institute (NCI).

Recent Clinical Trials for Ortataxel
An Efficacy Study Of Ortataxel In Recurrent GlioblastomaMario Negri Institute for Pharmacological ResearchPhase 2
BAY 59-8862 in Treating Patients With Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 2
BAY 59-8862 in Treating Patients With Non-Small Cell Lung CancerRoswell Park Cancer InstitutePhase 2

See all Ortataxel clinical trials

Clinical Trial Summary for Ortataxel

Top disease conditions for Ortataxel
Top clinical trial sponsors for Ortataxel

See all Ortataxel clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.